FDA Inspection 1053341 — Monica L. Kalvelage, MT (ASCP) MB, SBB
The FDA completed an inspection of Monica L. Kalvelage, MT (ASCP) MB, SBB on May 3, 2018 in Shreveport, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 3, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Shreveport, LA (United States)
Additional Details
Clinical Investigator (CI)